What can we expect from liposomal drugs?

被引：2

作者：

Dumontet, C ^{[1
]}

机构：

[1] Ctr Hosp Lyon Sud, Serv Hematol, F-69310 Pierre Benite, France

来源：

ANNALS OF ONCOLOGY | 2001年 / 12卷 / 04期

关键词：

D O I：

10.1023/A:1011128621302

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：433 / 434

页数：2

共 13 条

[1]

COIFFIER B, 1987, BLOOD, V70, P1394

[2] A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL [J].

Flinn, IW ;

Goodman, SN ;

Post, L ;

Jamison, J ;

Miller, CB ;

Gore, S ;

Diehl, L ;

Willis, C ;

Ambinder, RF ;

Byrd, JC .

ANNALS OF ONCOLOGY, 2000, 11 (06) :691-695

[3] Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: An 8-year follow-up study of EPOCH [J].

Gutierrez, M ;

Chabner, BA ;

Pearson, D ;

Steinberg, SM ;

Jaffe, ES ;

Cheson, BD ;

Fojo, A ;

Wilson, WH .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) :3633-3642

[4] High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours [J].

Koukourakis, MI ;

Koukouraki, S ;

Fezoulidis, I ;

Kelekis, N ;

Kyrias, G ;

Archimandritis, S ;

Karkavitsas, N .

BRITISH JOURNAL OF CANCER, 2000, 83 (10) :1281-1286

[5]

Lyass O, 2000, CANCER, V89, P1037, DOI 10.1002/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO

[6]

2-Z

[7] Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial [J].

Northfelt, DW ;

Dezube, BJ ;

Thommes, JA ;

Miller, BJ ;

Fischl, MA ;

Friedman-Kien, A ;

Kaplan, LD ;

Du Mond, C ;

Mamelok, RD ;

Henry, DH .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) :2445-2451

[8] Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: Results of a multicenter phase II trial [J].

Ranson, MR ;

Carmichael, J ;

OByrne, K ;

Stewart, S ;

Smith, D ;

Howell, A .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (10) :3185-3191

[9] Phase II study of pegylated liposomal doxorubicin: Inactive in recurrent small-cell lung cancer - A Hellenic Cooperative Oncology Group Study [J].

Samantas, E ;

Kalofonos, H ;

Linardou, H ;

Nicolaides, C ;

Mylonakis, N ;

Fountzilas, G ;

Kosmidis, P ;

Skarlos, D .

ANNALS OF ONCOLOGY, 2000, 11 (11) :1395-1397

[10]

SAMANTAS E, 2000, CANCER, V89, P1037

← 1 2 →